Search Results - "Casibang, M."

VPAC1 Receptors and Lung Cancer by MOODY, T. W., WALTERS, J., CASIBANG, M., ZIA, F., GOZES, Y.

“…: VIP/PACAP are autocrine growth factors for lung cancer. VIP and/or PACAP mRNA is present in most lung cancer cell lines examined. Although mRNA for VPAC2‐R…”
Get full text

(N-stearyl, norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines by Zia, H, Leyton, J, Casibang, M, Hau, V, Brenneman, D, Fridkin, M, Gozes, I, Moody, T W

“…The effects vasoactive intestinal peptide (VIP) antagonists were investigated on pancreatic cancer cell lines. (N-Stearyl, Norleucine17) VIP hybrid…”
Get full text

AH6809 antagonizes non-small cell lung cancer prostaglandin receptors by Casibang, Marchessini, Moody, Terry W

“…The effects of prostaglandin (PG)E 2 on lung cancer cells were investigated. 3H-PGE 2 bound with high affinity to membranes derived from small cell lung cancer…”
Get full text

Prostaglandin E2 and vasoactive intestinal peptide increase vascular endothelial cell growth factor mRNAs in lung cancer cells by Casibang, Marchessini, Purdom, Sally, Jakowlew, Sonia, Neckers, Len, Zia, Farah, Ben-Av, Pazit, Hla, Tim, You, Liang, Jablons, David M., Moody, Terry W.

“…The effects of prostaglandin E2 (PGE2) and vasoactive intestinal peptide (VIP) on vascular endothelial cell growth factor (VEGF) mRNAs were investigated using…”
Get full text

SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells by Moody, Terry W, Chiles, Jessica, Casibang, Marchessini, Moody, Elizabeth, Chan, Daniel, Davis, Thomas P

“…Neurotensin (NT) is an autocrine growth factor for some small cell lung cancer (SCLC) cells. In this communication, the effects of a non-peptide NT receptor…”
Get full text

(Tyr 0,Bpa 4)bombesin is a GRP receptor agonist by Casibang, M., Moody, T.W.

“…(Tyr 0,Bpa 4)bombesin, (YB)BB was synthesized and its biologic activity evaluated using T47D breast cancer cells. ( 125I-Tyr 0,Bpa 4)BB bound with high…”
Get full text

PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells by Moody, Terry W, Leyton, Julius, Casibang, Marchessini, Pisegna, Joseph, Jensen, Robert T

“…The effects of pituitary adenylate cyclase activating polypeptide (PACAP) on human lung cancer cell line NCI-1299 mitogen activated protein kinase (MAPK)…”
Get full text

(Tyr(0),Bpa(4))bombesin is a GRP receptor agonist by Casibang, M, Moody, T W

“…(Tyr(0),Bpa(4))bombesin, (YB)BB was synthesized and its biologic activity evaluated using T47D breast cancer cells. ((125)I-Tyr(0), Bpa(4))BB bound with high…”
Get full text

A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells by Weber, H.Christian, Walters, James, Leyton, Julius, Casibang, Marchessini, Purdom, Sally, Jensen, Robert T., Coy, David H., Ellis, Chad, Clark, Geoffrey, Moody, Terry W.

“…A synthetic peptide, ( d-Phe 6, β-Ala 11, Phe 13, Nle 14)bombesin-(6–14) was used to investigate the signal transduction mechanisms of bombesin receptor…”
Get full text

VPAC 1 Receptors and Lung Cancer by MOODY, T. W., WALTERS, J., CASIBANG, M., ZIA, F., GOZES, Y.

“…A bstract : VIP/PACAP are autocrine growth factors for lung cancer. VIP and/or PACAP mRNA is present in most lung cancer cell lines examined. Although mRNA for…”
Get full text

PACAP(6-38) is a PACAP receptor antagonist for breast cancer cells by LEYTON, J, GOZES, Y, PISEGNA, J, COY, D, PURDOM, S, CASIBANG, M, ZIA, F, MOODY, T. W

“…The effects of pituitary adenylate cyclase activating polypeptide (PACAP) analogs were investigated using breast cancer cells. 125I-PACAP-27 bound with high…”
Get full text

(N)-Stearyl, Norleucine17) VIP hybrid inhibits the growth of pancreatic cancer cell lines by Zia, H., Leyton, J., Casibang, M., Hau, V., Brenneman, D., Fridkin, M., Gozes, I., Moody, T.W.

Get full text

(N)-Stearyl, Norleucine 17) VIP hybrid inhibits the growth of pancreatic cancer cell lines by Zia, H., Leyton, J., Casibang, M., Hau, V., Brenneman, D., Fridkin, M., Gozes, I., Moody, T.W.

“…The effects vasoactive intestinal peptide (VIP) antagonists were investigated on pancreatic cancer cell lines. (N-Stearyl, Norleucine 17) VIP hybrid…”
Get full text